Professional Documents
Culture Documents
Scheda Mucosave FG Web
Scheda Mucosave FG Web
Contrada Fureria (Zona Industriale Ovest) 95032 Piano Tavola, Belpasso (CT) - Italy
Tel. +39 095 7086560 • info@bionap.com • www.bionap.com
SCIENTIFIC INVESTIGATIONS
OF MUCOSAVETM FG PROTECTION
Mucoadhesive properties has been evaluated by a new in vitro model (mucous membrane cell lines), predicting
in vivo conditions. In these studies, MUCOSAVE™FG has shown a strong mucoadhesive activity (up to 60% of cell
surface), higher than other mucoadhesive polymers such as hyaluronic acid and alginate (30% and 5% respectively).
The activity of MUCOSAVE™FG has been evaluated in a randomized, double-blind, placebo-
controlled clinical trial carried out:
• on 100 volunteers with gastrointestinal discomfort
• treated with 400 mg/day of MUCOSAVE™FG
• for 8 weeks
• Assessment by valid and reliable questionnaires: Gastrointestinal Quality of Life index (GIQLI)
and GERD Symptom Assessment Scale (GSAS)
MUCOSAVE™FG supplementation showed a significant improvement of symptoms related to gastrointestinal
discomfort after only 4 weeks.
GIQLI RESULT
GSAS RESULTS
MUCOSAVE™FG M P PLACEBO MUCOSAVE™FG PLACEBO
8 M P
1,4
7
1,2
6
1
5
GSAS score
GSAS score
4 0,8
3 0,6
2 0,4
1 0,2
0 0
T0 T4 T8 T0 T4 T8
Gastrointestinal symptoms Distress
Contrada Fureria (Zona Industriale Ovest) 95032 Piano Tavola, Belpasso (CT) - Italy
Tel. +39 095 7086560 • info@bionap.com • www.bionap.com